
The United States’ sweeping tariffs in April 2025 have triggered far-reaching disruptions across global supply chains. Industries from technology to pharmaceuticals now face increased risks, higher costs, regulatory complexity, and logistical bottlenecks. In this turbulent environment, artificial intelligence (AI) has become a tool for adaptation, yet its limitations are also …